Data / New clinical trials / Colorectal Neoplasms
Colorectal Neoplasms trials: 896 new since Nov 2024
The full list. New Colorectal Neoplasms clinical trials: 896 rows for $44.80, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 36 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/colorectal-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
896 clinical studies in Colorectal Neoplasms were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 231 have an industry sponsor and 702 are recruiting or about to. The newest, NCT07927075, was posted on November 9, 2026: Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression (Sir Run Run Shaw Hospital).
The request: Every new Colorectal Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 896New trials
- 231Industry sponsored
- 702Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 896, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07927075 | Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression | Sir Run Run Shaw Hospital | Phase 2/3 | Enrolling by invitation | Colorectal Cancer | 17 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07927049 | Evaluating the Efficacy of Chidamide in the Treatment of Initial Unresectable Metastatic Colorectal Cancer With High Expression of SULF1 | Sir Run Run Shaw Hospital | Phase 2/3 | Enrolling by invitation | Colorectal Cancer | 126 | China | clinicaltrials.gov |
| November 9, 2026 | NCT07926477 | Trastuzumab Rezetecan + Bevacizumab vs. TAS-102 + Bevacizumab in Pretreated mCRC With HER2 Low/Moderate Expression or HER2 Positivity With... | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 2 | Not yet recruiting | Colorectal Cancer | 86 | clinicaltrials.gov | |
| November 9, 2026 | NCT07924189 | Association of Psychological Distress With Clinical Outcomes in Patients With Digestive System Cancers | Xuanwu Hospital, Beijing | Observational | Active not recruiting | Psychological Distress, Pancreatic Cancer, Colorectal Cancer, Gastric Cancer | 100 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07923682 | Outcomes of Knife-Assisted Full-Thickness Resection for Rectal Lesions: A Multicenter Study | University Hospital, Ghent | Observational | Recruiting | Colorectal Cancer | 150 | Belgium | clinicaltrials.gov |
| November 6, 2026 | NCT07922850 | Tailored Nutrition vs. Exercise Prehabilitation Before Colorectal Cancer Surgery | University Hospital of North Norway | Not applicable | Not yet recruiting | Colorectal Cancer, Colorectal Neoplasms | 140 | Norway | clinicaltrials.gov |
| November 6, 2026 | NCT07922642 | Nurse-Led Prehabilitation Before Major Abdominal Cancer Surgery | Alexandria University | Not applicable | Not yet recruiting | Colorectal Cancer | 104 | Egypt | clinicaltrials.gov |
| November 5, 2026 | NCT07919951 | RAPID for Unresectable Colorectal Liver Metastases | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Not yet recruiting | Colorectal Liver Metastases (CRCLM), Colorectal Neoplasms | 10 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07919418 | A Patient-Derived 3D Bioprinted Colorectal Cancer-Stroma-Immune Triad Model Uncovers Microenvironmental Mechanisms of Chemoresistance and... | Peking Union Medical College Hospital | Observational | Recruiting | Colorectal Cancer | 60 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07917429 | Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC | Fujian Medical University Union Hospital | Observational | Not yet recruiting | Colorectal Cancer Metastatic | 610 | China | clinicaltrials.gov |
| November 3, 2026 | NCT07913906 | Alberta Cancer Exercise Dose in Colorectal Cancer | University of Calgary | Phase 2 | Not yet recruiting | Cancer, Colorectal Cancer | 90 | Canada | clinicaltrials.gov |
| November 3, 2026 | NCT07913802 | Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal Cancer | Vorarlberg Institute for Vascular Investigation and Treatment | Observational | Recruiting | Colorectal Neoplasms | 200 | Austria | clinicaltrials.gov |
| November 3, 2026 | NCT07913516 | Feasibility Study of Huangqi Yangyuan Formula for Capecitabine-Induced Adverse Reactions in Advanced Colorectal Cancer | Huanfang Fan | Not applicable | Not yet recruiting | Advanced Colorectal Cancer, Capecitabine-Related Adverse Reaction | 35 | China | clinicaltrials.gov |
| November 3, 2026 | NCT07913360 | GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer | Genfleet Therapeutics (Shanghai) Inc. | Phase 3 | Not yet recruiting | Colorectal Cancer | 368 | clinicaltrials.gov | |
| November 3, 2026 | NCT07912593 | Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors | Ensem Therapeutics | Phase 1/2 | Recruiting | Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer... | 320 | United States | clinicaltrials.gov |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | South Korea | clinicaltrials.gov |
| November 2, 2026 | NCT07909148 | Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life | Region Skane | Observational | Recruiting | Parastomal Hernia, Colorectal Cancer (Diagnosis) | 135 | Sweden | clinicaltrials.gov |
| November 2, 2026 | NCT07909122 | Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic... | Pfizer | Observational | Not yet recruiting | Metastatic Colorectal Cancer | 1 | clinicaltrials.gov | |
| October 29, 2026 | NCT07903857 | SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors | Guizhou Sinorda Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Stomach Neoplasms, Solid Tumor Malignancies | 78 | China | clinicaltrials.gov |
| October 29, 2026 | NCT07903571 | Cohort Study to eLucidAte Causes, Behaviour and Outcomes of gastRo Intestinal Tract Cancers in the Young | Royal Marsden NHS Foundation Trust | Observational | Not yet recruiting | Colorectal Cancer, Gastro-oesophageal Adenocarcinoma, Hepato-Biliary Carcinoma in Situ Nos | 200 | clinicaltrials.gov | |
| October 29, 2026 | NCT07903129 | SGA-OCRC: Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarians With Resectable Colorectal Cancer | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Not yet recruiting | Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer | 1,000 | clinicaltrials.gov | |
| October 28, 2026 | NCT07901335 | KLF4 Epigenetic Modulation | Azienda USL Reggio Emilia - IRCCS | Observational | Recruiting | KLF4 Methylation, Epigenetic | 170 | Italy | clinicaltrials.gov |
| October 28, 2026 | NCT07900620 | T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial) | Tampere University Hospital | Not applicable | Not yet recruiting | Colorectal Cancer | 500 | Finland | clinicaltrials.gov |
| October 27, 2026 | NCT07899125 | FLuorescent Angiography in REduction of Anastomotic Leak in Rectal Cancer Surgery | Basavatarakam Indo American Cancer Hospital & Research Institute | Not applicable | Not yet recruiting | Rectal Cancer Patients, Rectal Cancer Surgery, Colorectal Cancer, Anastomotic Leak Rectum, Anastomotic Leakage in Colon... | 610 | India | clinicaltrials.gov |
| October 27, 2026 | NCT07897227 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SYS6062 in Patients With Advanced Solid Tumors. | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 1/2 | Not yet recruiting | Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) | 260 | clinicaltrials.gov | |
| October 27, 2026 | NCT07896681 | Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Recruiting | Colorectal Cancer (CRC) | 46 | China | clinicaltrials.gov |
| October 26, 2026 | NCT07896174 | Resistance vs Aerobic Prehabilitation Before Colorectal Cancer Surgery | Semmelweis University | Not applicable | Recruiting | Colorectal Cancer, Colorectal Neoplasms, Postoperative Complications | 480 | Hungary | clinicaltrials.gov |
| October 26, 2026 | NCT07896096 | Ivarmacitinib Combined With Camrelizumab and Fruquintinib for Patients With Metastatic Colorectal Cancer After Failure of Second-line or... | Renmin Hospital of Wuhan University | Phase 2 | Recruiting | Refractory Metastatic Colorectal Cancer | 33 | China | clinicaltrials.gov |
| October 26, 2026 | NCT07895459 | MRD Monitoring in Colorectal Cancer Using ctDNA | Masaryk Memorial Cancer Institute | Not applicable | Recruiting | Colorectal Neoplasms, Colorectal Cancer (Diagnosis), Minimal Residual Disease | 60 | Czechia | clinicaltrials.gov |
| October 22, 2026 | NCT07890246 | A Phase 1 Study of IM-1340 in Participants With Advanced Cancer | Immunome, Inc. | Phase 1 | Not yet recruiting | Colorectal Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Neuroendocrine Neoplasm | 200 | clinicaltrials.gov | |
| October 22, 2026 | NCT07889934 | Enhanced Recovery After Surgery in Patients Undergoing Colorectal Cancer Surgery | University of West Attica | Not applicable | Completed | Colorectal Cancer | 91 | Greece | clinicaltrials.gov |
| October 22, 2026 | NCT07888075 | Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or... | AVEO Pharmaceuticals, Inc. | Phase 2/3 | Not yet recruiting | Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell... | 950 | clinicaltrials.gov | |
| October 22, 2026 | NCT07887971 | A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors | Aktis Oncology, Inc. | Phase 1 | Recruiting | NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), ES-SCLC, Small Cell Lung Cancer Extensive Stage, B7H3, Prostate... | 152 | United States | clinicaltrials.gov |
| October 21, 2026 | NCT07885384 | Fruquintinib Combined With Capecitabine as Adjuvant Extended Therapy After R0 Resection and Perioperative Chemotherapy in Patients With... | West China Hospital | Phase 3 | Not yet recruiting | Colorectal Cancer | 140 | clinicaltrials.gov | |
| October 20, 2026 | NCT07884188 | Becotatug Vedotin Plus Pucotenlimab for Metastatic Colorectal Cancer | Fudan University | Phase 2 | Recruiting | Metastatic Colorectal Cancer | 31 | China | clinicaltrials.gov |
| October 20, 2026 | NCT07884110 | Liver Transplantation for Colorectal Cancer | Pontificia Universidad Catolica de Chile | Observational | Recruiting | Colorectal Cancer, Liver Metastasis | 10 | Chile | clinicaltrials.gov |
| October 19, 2026 | NCT07881549 | Protein Signature Based Screening of Colorectal Adenomas and Cancer | Region Skane | Observational | Enrolling by invitation | Colorectal Cancer, Colorectal Adenoma | 150 | Sweden | clinicaltrials.gov |
| October 19, 2026 | NCT07880106 | Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Not yet recruiting | Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer | 2,000 | China | clinicaltrials.gov |
| October 16, 2026 | NCT07878988 | This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic... | LTZ Therapeutics, Inc. | Phase 1 | Recruiting | Colorectal Cancer, Advanced/Metastatic Solid Tumor, Solid Tumor (Phase I), EPCAM, Colon Cancer | 152 | United States | clinicaltrials.gov |
| October 15, 2026 | NCT07875920 | Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation | Neowise Biotechnology | Phase 1 | Not yet recruiting | Advanced Solid Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Adenocarcinoma, Lung Adenocarcinoma, KRAS... | 66 | China | clinicaltrials.gov |
| October 15, 2026 | NCT07875465 | Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases | Bing Xia | Phase 2 | Not yet recruiting | Liver Metastases, Non-Small Cell Lung Cancer, Colorectal Cancer (Diagnosis), Pancreatic Cancer Metastatic, Solid Tumors | 120 | China | clinicaltrials.gov |
| October 15, 2026 | NCT07874880 | MTX-531-001 Phase 1 Study in Advanced Solid Tumors | MEKanistic Therapeutics, Inc. | Phase 1 | Not yet recruiting | Solid Tumors (Phase 1), HNSCC, Endometrial Cancer, Her2-negative Metastatic Breast Cancer, Pan-RAS and BRAF Wild-type... | 71 | United States | clinicaltrials.gov |
| October 14, 2026 | NCT07874438 | A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With Cetuximab and... | The First Affiliated Hospital with Nanjing Medical University | Not applicable | Not yet recruiting | Colorectal Cancer | 55 | China | clinicaltrials.gov |
| October 14, 2026 | NCT07873580 | European Implementation Study on Simultaneous Screening for Gastric and Colorectal Cancers | University of Latvia | Observational | Not yet recruiting | Helicobacter Pylori Infection, Colorectal Cancer, Gastric Cancer | 8,000 | clinicaltrials.gov | |
| October 14, 2026 | NCT07873450 | SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET | Full-Life Technologies UK Limited | Phase 1/2 | Recruiting | Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer, Cholangiocarcinoma | 208 | Australia, United States | clinicaltrials.gov |
| October 14, 2026 | NCT07872787 | NURSE-led Geriatric Assessment in Older Colorectal Cancer Patients | Helse Stavanger HF | Not applicable | Not yet recruiting | Colo-rectal Cancer | 50 | Norway | clinicaltrials.gov |
| October 13, 2026 | NCT07871227 | Follow-up After Oncological Resection by Endoscopic Colorectal ESD (Endoscopic Submucosal Dissection) | University Hospital, Bordeaux | Observational | Not yet recruiting | Colorectal Neoplasms | 1,200 | France | clinicaltrials.gov |
| October 7, 2026 | NCT07863154 | Probiotic Supplementation During Neoadjuvant Chemoradiotherapy in Colorectal Cancer | University of Malaga | Not applicable | Completed | Colorectal Cancer | 58 | Spain | clinicaltrials.gov |
| October 7, 2026 | NCT07863024 | Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET... | Regeneron Pharmaceuticals | Phase 1/2 | Not yet recruiting | Advanced Solid Tumors | 320 | clinicaltrials.gov | |
| October 6, 2026 | NCT07861815 | Assessing the Feasibility of Using Methylene Blue in Identifying Ureters During Colorectal Surgery | Chinese University of Hong Kong | Phase 4 | Not yet recruiting | Colorectal Cancer, Colorectal Surgery, Ureteric Injury | 20 | clinicaltrials.gov | |
| October 6, 2026 | NCT07861386 | Emulation of the MAVERICC Trial Using Specialty Oncology Electronic Health Records Databases | Brigham and Women's Hospital | Observational | Active not recruiting | Metastatic Colorectal Cancer (mCRC) | 9,978 | United States | clinicaltrials.gov |
| October 6, 2026 | NCT07861360 | Emulation of the SUNLIGHT Trial Using Specialty Oncology Electronic Health Records Databases | Brigham and Women's Hospital | Observational | Active not recruiting | Metastatic Colorectal Cancer (mCRC) | 400 | United States | clinicaltrials.gov |
| October 6, 2026 | NCT07861347 | Emulation of the KEYNOTE177 Trial Using Specialty Oncology Electronic Health Records Databases | Brigham and Women's Hospital | Observational | Active not recruiting | Metastatic Colorectal Cancer (mCRC) | 1,030 | United States | clinicaltrials.gov |
| October 5, 2026 | NCT07859085 | A Study to Evaluate the Safety and Activity of GDC-7035 With Anti-Cancer Therapies in Participants With KRAS G12D-Mutated Unresectable... | Genentech, Inc. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma | 388 | clinicaltrials.gov | |
| October 2, 2026 | NCT07854405 | A Clinical Study on the Synergistic Effects of Zhen-Qi-Jie-Du Granules in Palliative Care for Advanced Colorectal Cancer | Jiangsu Famous Medical Technology Co., Ltd. | Not applicable | Not yet recruiting | Colorectal Cancer | 1,540 | China | clinicaltrials.gov |
| October 1, 2026 | NCT07852793 | Mailed FIT-Based Outreach Interventions | National Cancer Centre, Singapore | Not applicable | Not yet recruiting | Colorectal Cancer | 40,000 | Singapore | clinicaltrials.gov |
| September 30, 2026 | NCT07850882 | A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for... | Jie Yuan,MD | Observational | Recruiting | Colorectal Cancer (CRC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC) | 30 | China | clinicaltrials.gov |
| September 29, 2026 | NCT07845877 | An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal Cancer Chemotherapy | Yonsei University | Not applicable | Not yet recruiting | Colorectal Neoplasms, Sedentary Behavior | 40 | clinicaltrials.gov | |
| September 28, 2026 | NCT07844252 | A Novel Multi-functional Artificial Intelligence System on Treatment Efficacy and Implementation in Colonoscopy | Chinese University of Hong Kong | Not applicable | Not yet recruiting | Colorectal Cancer (CRC) Screening | 2,818 | clinicaltrials.gov | |
| September 28, 2026 | NCT07844187 | TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Phase 1/2 | Not yet recruiting | Colorectal Neoplasms | 64 | China | clinicaltrials.gov |
| September 25, 2026 | NCT07842965 | CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal... | City of Hope Medical Center | Phase 1 | Not yet recruiting | Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8 | 36 | United States | clinicaltrials.gov |
| September 25, 2026 | NCT07842692 | Serum Endocan Levels in Colorectal Cancer | Assiut University | Observational | Not yet recruiting | Colorectal Cancer | 64 | clinicaltrials.gov | |
| September 24, 2026 | NCT07838246 | Liquid Biopsy Biomarkers for Endoscopic Surveillance in Lynch Syndrome | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Observational | Completed | Lynch Syndrome, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer (CRC), Colorectal Neoplasms | 109 | Italy | clinicaltrials.gov |
| September 23, 2026 | NCT07835542 | Triton 1.5 Robotic System for Diagnostic Colonoscopy in the Middle East | Neptune Medical | Not applicable | Not yet recruiting | Colonoscopy, Colorectal Cancer Screening | 30 | United Arab Emirates | clinicaltrials.gov |
| September 22, 2026 | NCT07834268 | Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS) | Fifth Affiliated Hospital of Guangzhou Medical University | Not applicable | Active not recruiting | Colorectal Cancer, Grastic Cancer, Esophageal Cancer, Lung Cancer, Liver Cancer | 1,250 | China | clinicaltrials.gov |
| September 22, 2026 | NCT07833358 | This Trial Corresponds to the Manuscript Titled: Effects of Tai Chi on Balance and Sleep Quality in Colorectal Cancer Patients Undergoing... | Ya-Fen Fan | Not applicable | Completed | Colorectal Cancer | 60 | Taiwan | clinicaltrials.gov |
| September 21, 2026 | NCT07830576 | Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation | Anhui Provincial Hospital | Observational | Recruiting | Colorectal Liver Metastases, Colorectal Neoplasms, Liver Neoplasms | 205 | China | clinicaltrials.gov |
| September 21, 2026 | NCT07830407 | Pre-Clinical Validation of ChemoINTEL Unified Algorithm Chemotherapeutic Response Prediction in Patients With Colorectal Cancer | Pierian Biosciences | Observational | Recruiting | Colorectal Cancer | 100 | United Kingdom | clinicaltrials.gov |
| September 18, 2026 | NCT07829081 | Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors | University Hospital, Basel, Switzerland | Observational | Recruiting | Quality of Life (QOL), Mismatch Repair Deficient Colorectal Cancer, Microsatellite Instability-High Colorectal Cancer... | 234 | Switzerland | clinicaltrials.gov |
| September 18, 2026 | NCT07827378 | Early Discharge After Colorectal Surgery | Fundación para la Investigación del Hospital Clínico de Valencia | Observational | Not yet recruiting | Cancer, Colo-rectal Cancer | 97 | clinicaltrials.gov | |
| September 17, 2026 | NCT07826611 | The Diagnostic Accuracy of the Device Under Development MULTISCOPE | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Not yet recruiting | Colorectal Cancer | 30 | clinicaltrials.gov | |
| September 16, 2026 | NCT07823322 | A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After... | Incyte Corporation | Phase 2 | Not yet recruiting | CRC (Colorectal Cancer) | 40 | clinicaltrials.gov | |
| September 16, 2026 | NCT07822399 | A Study of MGC030 in Participants With Advanced Solid Tumors | MacroGenics | Phase 1 | Recruiting | Urothelial Cancer, GastroEsophageal Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC), Pancreatic Cancer | 314 | United States | clinicaltrials.gov |
| September 15, 2026 | NCT07819539 | Anthocyanin-Rich Berry Supplementation in Patients With Colorectal Cancer | Jagiellonian University | Not applicable | Completed | Colorectal Cancer | 70 | Poland | clinicaltrials.gov |
| September 11, 2026 | NCT07816263 | Guaraná Supplementation for Cancer-Related Fatigue | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | Observational | Recruiting | Cancer-related Fatigue, Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Cervical Cancer, Quality of Life | 60 | Colombia | clinicaltrials.gov |
| September 11, 2026 | NCT07815093 | Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology | Xiuli Zuo | Observational | Not yet recruiting | Colorectal Cancer | 11,000 | clinicaltrials.gov | |
| September 11, 2026 | NCT07814872 | A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment | Harvard Medical School (HMS and HSDM) | Observational | Not yet recruiting | Neoplasms (Cancer / Tumors), Colorectal Neoplasms, Lung Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Pancreatic... | 30,000 | United States | clinicaltrials.gov |
| September 11, 2026 | NCT07814417 | A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation | Eli Lilly and Company | Phase 2 | Not yet recruiting | Colorectal Neoplasms | 50 | China, Spain, United States | clinicaltrials.gov |
| September 10, 2026 | NCT07813013 | Right Colon Enema to Improve Bowel Preparation Quality During Colonoscopy | Westmead Hospital | Not applicable | Not yet recruiting | Colonic Polyps, Colorectal Neoplasms, Colonoscopy, Bowel Preparation Quality | 320 | Australia | clinicaltrials.gov |
| September 10, 2026 | NCT07812805 | SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors | SK Life Science, Inc. | Phase 1 | Recruiting | Selected Advanced Solid Tumors, Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Cancer... | 100 | South Korea, United States | clinicaltrials.gov |
| September 10, 2026 | NCT07811453 | Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options | Charite University, Berlin, Germany | Not applicable | Not yet recruiting | Colorectal Neoplasms, Liver Neoplasms, Neoplasm Metastases, Colorectal Liver Metastases, Metastatic Colorectal Cancer... | 260 | Germany | clinicaltrials.gov |
| September 9, 2026 | NCT07809893 | Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients | Sun Yat-sen University | Phase 2 | Recruiting | Colorectal Cancer | 45 | China | clinicaltrials.gov |
| September 9, 2026 | NCT07809074 | Mindfulness and Self-Compassion Intervention for Ostomy Patients Due to Colorectal Cancer on Loneliness (MSC-OP) | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Colorectal Cancer (CRC), Stoma | 20 | clinicaltrials.gov | |
| September 8, 2026 | NCT07808164 | ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort | Tam Anh Research Institute | Observational | Recruiting | HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial... | 162 | Vietnam | clinicaltrials.gov |
| September 8, 2026 | NCT07807956 | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With... | AbbVie | Phase 1 | Recruiting | Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer... | 130 | United States | clinicaltrials.gov |
| September 8, 2026 | NCT07807800 | A Study of DES-1357 in People With Deficient Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer... | D. E. Shaw Research, LLC | Phase 1/2 | Not yet recruiting | Metastatic Colorectal Cancer (CRC) | 88 | clinicaltrials.gov | |
| September 8, 2026 | NCT07807345 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | Sutro Biopharma, Inc. | Phase 1 | Recruiting | Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer, Colorectal Cancer... | 285 | United States | clinicaltrials.gov |
| September 4, 2026 | NCT07805551 | A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Phase 1/2 | Recruiting | CRC, Colorectal Cancer | 220 | China | clinicaltrials.gov |
| September 4, 2026 | NCT07805369 | A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer | DEM BioPharma, Inc. | Phase 1 | Recruiting | Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer | 60 | Australia | clinicaltrials.gov |
| September 3, 2026 | NCT07801352 | CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally... | Shanghai Changzheng Hospital | Phase 2 | Active not recruiting | Locally Advanced Colorectal Cancer, Metastatic Colorectal Cancer | 15 | China | clinicaltrials.gov |
| September 1, 2026 | NCT07797361 | Evaluation of Versatile Intelligent Staining Technology (VIST) and Spectral Flexible Imaging (SFI) for Detection and Optical... | Alexandre Vontobel Padoin | Not applicable | Not yet recruiting | Colorectal Neoplasms, Colonic Polyps, Adenoma, Serrated Polyps, Colorectal Cancer Screening | 990 | Brazil | clinicaltrials.gov |
| September 1, 2026 | NCT07796334 | Colon Health Champion Program | Virginia Commonwealth University | Not applicable | Not yet recruiting | Colorectal Cancer, CRC | 29 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07795801 | Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors | Massachusetts General Hospital | Not applicable | Not yet recruiting | Colorectal Cancer (Diagnosis), Anal Cancer, Sexual Dysfunction Female | 100 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07795528 | Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma | Ruijin Hospital | Observational | Recruiting | Colon Adenocarcinoma, Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer | 392 | China | clinicaltrials.gov |
| August 28, 2026 | NCT07792109 | Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Not yet recruiting | Prostate Cancer, Colorectal Cancer | 25 | Italy | clinicaltrials.gov |
| August 28, 2026 | NCT07791758 | A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma | Nanjing Leads Biolabs Co.,Ltd | Phase 1/2 | Recruiting | Metastatic Colorectal Carcinoma | 369 | China | clinicaltrials.gov |
| August 27, 2026 | NCT07790718 | Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer | City of Hope Medical Center | Not applicable | Recruiting | Colon Polyp, Colorectal Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate... | 30 | United States | clinicaltrials.gov |
| August 27, 2026 | NCT07790510 | HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer | Haisco Pharmaceutical Group Co., Ltd. | Phase 1/2 | Recruiting | Metastatic Colorectal Cancer (CRC) | 180 | China | clinicaltrials.gov |
| August 27, 2026 | NCT07789210 | A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally... | Zhejiang University | Phase 2 | Recruiting | Colorectal Cancer, BRAF V600E Mutation Positive, Encorafenib, Cetuximab N01 | 25 | China | clinicaltrials.gov |
| August 26, 2026 | NCT07788729 | Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons | University of Regensburg | Not applicable | Recruiting | Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer, Malignant Melanoma | 384 | Germany | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Fudan University | 24 | October 20, 2026 |
| Sun Yat-sen University | 19 | September 9, 2026 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 12 | November 9, 2026 |
| City of Hope Medical Center | 11 | September 25, 2026 |
| M.D. Anderson Cancer Center | 9 | July 22, 2026 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 8 | October 27, 2026 |
| National Cancer Institute (NCI) | 8 | July 21, 2026 |
| The First Affiliated Hospital with Nanjing Medical University | 7 | October 14, 2026 |
| Zhejiang University | 7 | August 27, 2026 |
| Pfizer | 6 | November 2, 2026 |
| Peking University Cancer Hospital & Institute | 6 | August 20, 2026 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 6 | July 27, 2026 |
| Chinese University of Hong Kong | 5 | October 6, 2026 |
| Massachusetts General Hospital | 5 | August 31, 2026 |
| Sohag University | 5 | August 21, 2026 |
| Memorial Sloan Kettering Cancer Center | 5 | July 9, 2026 |
| The First Hospital of Jilin University | 5 | May 13, 2026 |
| Blokhin's Russian Cancer Research Center | 5 | April 21, 2026 |
| Dong Peng | 5 | July 14, 2025 |
| Sir Run Run Shaw Hospital | 4 | November 9, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 243 | November 6, 2026 |
| Observational | 240 | November 9, 2026 |
| Phase 2 | 151 | November 9, 2026 |
| Phase 1 | 111 | October 29, 2026 |
| Phase 1/2 | 77 | November 3, 2026 |
| Phase 3 | 35 | November 3, 2026 |
| Early phase 1 | 15 | August 24, 2026 |
| Phase 2/3 | 12 | November 9, 2026 |
| Phase 4 | 12 | October 6, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| China | 267 | November 9, 2026 |
| United States | 233 | November 3, 2026 |
| Spain | 51 | October 7, 2026 |
| France | 48 | October 13, 2026 |
| Italy | 47 | October 28, 2026 |
| Australia | 39 | October 14, 2026 |
| South Korea | 32 | November 2, 2026 |
| Canada | 31 | November 3, 2026 |
| Germany | 31 | September 10, 2026 |
| United Kingdom | 29 | September 21, 2026 |
| Turkey (Türkiye) | 24 | July 1, 2026 |
| Japan | 24 | June 5, 2026 |
| Belgium | 22 | November 6, 2026 |
| Netherlands | 21 | August 24, 2026 |
| Taiwan | 19 | September 22, 2026 |
| Denmark | 18 | June 5, 2026 |
| Egypt | 16 | November 6, 2026 |
| Sweden | 13 | November 2, 2026 |
| Poland | 12 | September 15, 2026 |
| Brazil | 12 | September 1, 2026 |
| Puerto Rico | 10 | August 20, 2026 |
| Russia | 10 | April 22, 2026 |
| Norway | 8 | November 6, 2026 |
| Austria | 8 | November 3, 2026 |
| Hong Kong | 7 | July 22, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.